US FDA declares Novartis painkiller Prexige is ''not approvable''

28 Sep 2007

1

The US Food and Drug Administration (FDA) has refused to grant a license to pharma major Novartis''s new painkiller, ''Prexige''.

The Basel, Switzerland-based pharmaceutical company received a "not approvable" rejection letter from the FDA for Prexige, which it had proposed as a once-daily treatment for patients suffering from osteoarthritic pain.

The setback was widely expected after the drug was withdrawn in Australia earlier this year, after it was blamed for the deaths of two people and for triggering liver failures that required two others to have liver transplants.

Business History Videos

History of hovercraft Part 3...

Today I shall talk a bit more about the military plans for ...

By Kiron Kasbekar | Presenter: Kiron Kasbekar

History of hovercraft Part 2...

In this episode of our history of hovercraft, we shall exam...

By Kiron Kasbekar | Presenter: Kiron Kasbekar

History of Hovercraft Part 1...

If you’ve been a James Bond movie fan, you may recall seein...

By Kiron Kasbekar | Presenter: Kiron Kasbekar

History of Trams in India | ...

The video I am presenting to you is based on a script writt...

By Aniket Gupta | Presenter: Sheetal Gaikwad

view more